Orciprenaline
Verifiedfieldschanged
Verifiedrevid408782146
Iupac name(RS)-5-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,3-diol
ChiralityRacemic mixture
UsanMetaproterenol
TradenameAlupent, Metaprel, Orcibest
Medlineplusa682084
Pregnancy auA
Legal auS4
Pregnancy usC
Legal usRx-only
Routes of administrationBy mouth, inhalation
Bioavailability3% if inhaled, 40% if taken orally
MetabolismGastrointestinal and hepatic
Elimination half-life6 hours
Iuphar ligand7250
Cas number586-06-1
Atc prefixR03
Atc suffixAB03
Pubchem4086
DrugbankDB00816
Chemspiderid3944
Unii53QOG569E0
KeggD08300
Chebi82719
Chembl776
C11
H17
N1
O3
SmilesOc1cc(cc(O)c1)C(O)CNC(C)C
Stdinchi1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-9(13)5-10(14)4-8/h3-5,7,11-15H,6H2,1-2H3
StdinchikeyLMOINURANNBYCM-UHFFFAOYSA-N
Solubility9.7

Orciprenaline, also known as metaproterenol, is a bronchodilator used in the treatment of asthma.[1][2] Orciprenaline is a moderately selective β2 adrenergic receptor agonist that stimulates receptors of the smooth muscle in the lungs, uterus, and vasculature supplying skeletal muscle, with minimal or no effect on α adrenergic receptors. The pharmacologic effects of β adrenergic agonist drugs, such as orciprenaline, are at least in part attributable to stimulation through β adrenergic receptors of intracellular adenylyl cyclase, the enzyme which catalyzes the conversion of ATP to cAMP. Increased cAMP levels are associated with relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from many cells, especially from mast cells.

Adverse effects

More common side effects of metaproterenol include tachycardia and nervousness.[3][4] Additional side effects with >1% incidence include headache, nausea, and tremor.[3] A non-exhaustive list of rare side effects includes other cardiovascular symptoms, dizziness, fatigue, etc.[3][4]

References

  1. ^ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). "DrugBank 3.0: a comprehensive resource for omics research on drugs". Nucleic Acids Res.. 39 (Database issue): D1035-41. doi:10.1093/nar/gkq1126. PMC 3013709. PMID 21059682
  2. ^ Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M (2008). "DrugBank: a knowledgebase for drugs, drug actions and drug targets". Nucleic Acids Res. 36 (Database issue): D901-6. doi:10.1093/nar/gkm958. PMC 2238889. PMID 18048412
  3. ^ "Metaproterenol Sulfate Syrup, USP". dailymed.nlm.nih.gov. Retrieved 2025-05-04.
  4. ^ "Metaproterenol Side Effects: Common, Severe, Long Term". Drugs.com. Retrieved 2025-05-04.